Sterol regulatory element-binding proteins can transactivate CYP4F2 transcription in hepatocytes [125], and decrease SREBP-1 proteins expression, resulting in reduced expression of CYP4F2, which slows the breakdown of α-Toc in experimental non-alcoholic fatty liver disease model mice [126]. This evidence concerns the gene CYP4F2 and alcoholic fatty liver disease.